Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill

Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.

Previous post Spotify stock plunges on middling user growth projections
Next post U.S. Army’s first climate plan calls to slash emissions and build electric vehicle fleet